Astellas Pharma Cash from Investing (TTM) Trends

Astellas Pharma Inc (ALPMY)

9.55 +0.01 (+0.10%) USD | OTCM | Apr 26, 16:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	-5.766B
September 30, 2023	-5.798B
June 30, 2023	-567.67M
March 31, 2023	-625.77M
December 31, 2022	-575.57M
September 30, 2022	-300.40M
June 30, 2022	-511.07M
March 31, 2022	-555.95M
December 31, 2021	-542.58M
September 30, 2021	-918.24M
June 30, 2021	-701.89M
March 31, 2021	-772.52M
December 31, 2020	-3.551B
September 30, 2020	-3.513B
June 30, 2020	-3.722B
March 31, 2020	-3.586B
December 31, 2019	-808.29M
September 30, 2019	-740.94M
June 30, 2019	-526.32M
March 31, 2019	-376.65M
December 31, 2018	-520.92M
September 30, 2018	-513.89M
June 30, 2018	-572.61M
March 31, 2018	-1.099B
December 31, 2017	-860.72M

Date	Value
September 30, 2017	-1.139B
June 30, 2017	-1.122B
March 31, 2017	-678.58M
December 31, 2016	-1.310B
September 30, 2016	-1.364B
June 30, 2016	-1.218B
March 31, 2016	-1.225B
December 31, 2015	-795.51M
September 30, 2015	-550.43M
June 30, 2015	-602.74M
March 31, 2015	-653.62M
December 31, 2014	-333.24M
September 30, 2014	-177.55M
June 30, 2014	-249.32M
March 31, 2014	-268.09M
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-5.798B

Minimum

Sep 2023

-300.40M

Maximum

Sep 2022

-1.794B

Average

-740.94M

Median

Sep 2019

Cash from Investing (TTM) Benchmarks